Probiótico #11 del mundo para nutrir tu flora intestinal2
Cuenta con Enterogermina en situaciones como
Referencias, Mensajes y Avisos Legales
- Nicholas Hall’s global CHC database, DB6, MAT Q4 2024 value data
- E. Ghelardi et al. Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation. j Appl Microbiol2015;119:552-9
- Vecchione A et al (2018). Compositional Quality and Potential Gastrointestinal Behavior of Probiotic Products Commercialized in Italy. Front Med (Lausanne) 5:59.
- Acosta-Rodríguez-Bueno CP,Abreu YAbreu AT,Guarner F, GunoMJV, Pehlivano lu E, Perez M3rd. Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review. Adv Ther. 2022 Nov,39(11):4854-4874
- Abbrescia, A., Palese, L. L., Papa, S., Gaballo, A.,Alifano, P., & Sardanelli, A. (2014). Antibiotic Sensitivity of Bacillus clausii Strains in Commercial Preparation. Clinical Immunology Endocrine & Metabolic Drugs, 1(2), 102–110.
- Khatri I, Sharma G, Subramanian S. Composite genome sequence of Bacillus clausii, a probiotic commercially available as Enterogermina", and insights into its probiotic properties. BMC microbiology. 2019 Dec; 191-5.
- Mazzantini, D., Calvigioni, M., Celandroni, F., Lupetti, A. and Ghelardi